EB-107

N/A

Report date: 2024/03/28 17:42:01

Base Information

Drug NameEB-107

Drug Alias NameEB-107

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsRetinal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesEluminex Biosciences (Suzhou) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesEluminex Biosciences (Suzhou) Ltd

Inactive CompaniesN/A

Active IndicationsRetinal Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A